NCT00551577 - Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

January 31, 2008

Conditions

Ovarian Neoplasms

Interventions

PROCEDURE

neoadjuvant chemotherapy (Carboplatin/Docetaxel)

3 cycles of Carboplatin/Docetaxel (3-weekly) preoperative and 3 cycles of Carboplatin/Docetaxel (3-weekly) postoperative

PROCEDURE

neoadjuvant chemotherapy (Carboplatin/Docetaxel)

2 cycles of Carboplatin/Docetaxel (3-weekly) preoperative and 4 cycles of Carboplatin/Docetaxel (3-weekly) postoperative

Trial Locations (2)

RECRUITING

Department of Gynaecology, University hospital, Hamburg

RECRUITING

Department of Gynaecolgy and Obstetrics, University hopsital, Bonn